Sales for the second quarter ended at MNOK 137.4 (MNOK 117.5), an increase of 16.9%. Sales for first half ended at MNOK 266.6 (MNOK 233.6), an increase of 14.1%. Currency neutral sales of own products was up 4.0% for the quarter and 2.5% for the first half. Operating profit (EBIT) for the quarter is up 13.1% and ended at MNOK 42.2, an EBIT margin at 30.7% (MNOK 37.3 an EBIT margin at 31.8%). For the first half EBIT is up 6.9% and ended at MNOK 75.7 an EBIT margin at 32.6% for the first half (MNOK 70.8 an EBIT margin at 35.3%).Medistim established direct sales organizations in bothCanada andChina in Q2 and continues to strengthen its organization worldwide.Medistim announced its participation in a groundbreaking cardiac surgery trial dedicated to women,ROMA -W. A dividend ofNOK 4.50 per share, a total of MNOK 82.2, was paid 5th of May.
Click here for more information
© Oslo Bors ASA, source